Marc Antoine Aimé

IMCAS World 2026

par Marc Antoine Aimé | Jan 19, 2026 | Congress

IMCAS World Congress 2025, Booth N206 | Level 2 Hall Maillot A | Level 2 Paris from 29 to 31 January  Visit us at N206 and discover how our regenerative solutions are transforming aesthetics and anti-ageing medicine. Let’s connect at our booth to discuss how...

RegenLab USA & MiMedx: Exclusive U.S. Distribution for RegenKit®-Wound Gel

par Marc Antoine Aimé | Jan 13, 2026 | Corporate

RegenLab USA and MiMedx Announce Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel ; “We are thrilled to partner with MIMEDX to bring RegenKit®-Wound Gel to patients across the United States, » said Franck Maingonnat, VP of Business Development at Regen...

PRP Preparation in Europe | CE Marking, Safety & Standardisation

par Marc Antoine Aimé | Jan 6, 2026 | Corporate

See why the Regenlab patented system is not just another tube Closed-System PRP Preparation: Improving Safety and Standardisation in Clinic ; In daily practice, not all tubes are equivalent when it comes to preparing PRP (Platelet-Rich Plasma). Beyond appearance, the...

Standardised PRP: why quality matters more than quantity

par Marc Antoine Aimé | Nov 5, 2025 | Clinical Study osteoarthritis

PRP & Knee Osteoarthritis: why quality matters more than quantity Influence of platelet count on the clinical effectiveness of platelet-rich plasma in the treatment of knee osteoarthritis: A systematic review and meta-analysis Simental-Mendía et al. 2025 PMID:...

Masterclass in Kiel — Focus on Peyronie’s Disease and Functional Andrology

par Marc Antoine Aimé | Sep 30, 2025 | Congress

Masterclass in Kiel — Focus on Peyronie’s Disease and Functional Andrology Register Now On 21 November 2025, the Institute of Anatomy, Christian-Albrechts University, Kiel (Germany), will host an afternoon masterclass dedicated to Peyronie’s disease and regenerative...

« Entrées précédentes



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.